These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3019915)

  • 1. Susceptibility to varicella-zoster virus among adults at high risk for exposure.
    Alter SJ; Hammond JA; McVey CJ; Myers MG
    Infect Control; 1986 Sep; 7(9):448-51. PubMed ID: 3019915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varicella zoster virus immunity in multinational health care workers of a Saudi Arabian hospital.
    Almuneef M; Dillon J; Abbas MF; Memish Z
    Am J Infect Control; 2003 Oct; 31(6):375-81. PubMed ID: 14608306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of hospital-based health care personnel to varicella-zoster virus infections.
    McKinney WP; Horowitz MM; Battiola RJ
    Am J Infect Control; 1989 Feb; 17(1):26-30. PubMed ID: 2538095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nosocomial transmission of chickenpox and varicella zoster virus seroprevalence rate amongst healthcare workers in a teaching hospital in China.
    Yang J; Liu J; Xing F; Ye H; Dai G; Liu M; Lo SK; Lau RW; Chiu KH; Chan JF; Yuen KY
    BMC Infect Dis; 2019 Jul; 19(1):582. PubMed ID: 31277589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
    Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
    J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection.
    Duncan JR; Witkop CT; Webber BJ; Costello AA
    Vaccine; 2017 Apr; 35(18):2351-2357. PubMed ID: 28359621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varicella-zoster virus immunity in dermatological patients on systemic immunosuppressant treatment.
    Hackett CB; Wall D; Fitzgerald SF; Rogers S; Kirby B
    Br J Dermatol; 2011 Jun; 164(6):1387-9. PubMed ID: 21410679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity to varicella zoster virus in children with leukaemia.
    Ndumbe PM; Wheeler K; Chessells JM; Levinsky RJ
    Med Microbiol Immunol; 1988; 177(2):83-9. PubMed ID: 2834625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic evidence of reinfection with varicella-zoster virus.
    Arvin AM; Koropchak CM; Wittek AE
    J Infect Dis; 1983 Aug; 148(2):200-5. PubMed ID: 6310001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Characteristics of Pediatric Healthcare Workers without Immunity to Varicella zoster Virus.
    Anugulruengkitt S; Puthanakit T; Siengboon S; Paitoonpong L; Kowitdamrong E; Pancharoen C; Pichitchok Y
    Jpn J Infect Dis; 2017 Mar; 70(2):216-218. PubMed ID: 27580582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cluster of primary varicella cases among healthcare workers with false-positive varicella zoster virus titers.
    Behrman A; Schmid DS; Crivaro A; Watson B
    Infect Control Hosp Epidemiol; 2003 Mar; 24(3):202-6. PubMed ID: 12683513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital infection control for varicella zoster virus infection.
    Myers MG; Rasley DA; Hierholzer WJ
    Pediatrics; 1982 Aug; 70(2):199-202. PubMed ID: 7048233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility to varicella-zoster virus in applicants for nurse training in Scotland.
    Waclawski ER; Stewart M
    Commun Dis Public Health; 2002 Sep; 5(3):240-2. PubMed ID: 12434695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
    Ampofo K; Saiman L; LaRussa P; Steinberg S; Annunziato P; Gershon A
    Clin Infect Dis; 2002 Mar; 34(6):774-9. PubMed ID: 11830801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
    Breuer J; Schmid DS; Gershon AA
    J Infect Dis; 2008 Mar; 197 Suppl 2():S147-51. PubMed ID: 18419389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility to varicella zoster virus infection in health care workers.
    Gallagher J; Quaid B; Cryan B
    Occup Med (Lond); 1996 Aug; 46(4):289-92. PubMed ID: 8854707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults.
    Amlie-Lefond C; Gilden D
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1561-1569. PubMed ID: 27138380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of varicella-zoster virus-specific IgA antibodies in varicella and zoster patients and in healthy adults of various ages by solid-phase radioimmunoassay.
    Levy E; Mosovitz B; Friedman M; Sarov I
    Intervirology; 1983; 20(2-3):123-8. PubMed ID: 6313543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity.
    Grose C
    Mol Biol Med; 1989 Oct; 6(5):453-62. PubMed ID: 2560525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.